Venture Life Group PLC
LSE:VLG

Watchlist Manager
Venture Life Group PLC Logo
Venture Life Group PLC
LSE:VLG
Watchlist
Price: 61.5 GBX Market Closed
Market Cap: 78.6m GBX

Venture Life Group PLC
Other Long-Term Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Venture Life Group PLC
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Venture Life Group PLC
LSE:VLG
Other Long-Term Assets
ÂŁ59.6m
CAGR 3-Years
188%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Unilever PLC
LSE:ULVR
Other Long-Term Assets
€6.3B
CAGR 3-Years
-12%
CAGR 5-Years
7%
CAGR 10-Years
8%
PZ Cussons PLC
LSE:PZC
Other Long-Term Assets
ÂŁ52.6m
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
2%
Science in Sport PLC
LSE:SIS
Other Long-Term Assets
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Warpaint London PLC
LSE:W7L
Other Long-Term Assets
ÂŁ2.8m
CAGR 3-Years
69%
CAGR 5-Years
48%
CAGR 10-Years
N/A
HALEON PLC
LSE:HLN
Other Long-Term Assets
ÂŁ383m
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
N/A
No Stocks Found

Venture Life Group PLC
Glance View

Market Cap
78.7m GBX
Industry
Consumer products

Venture Life Group Plc engages in the development, manufacture, and commercializing of products for the aging population. The company is headquartered in Bracknell, Berkshire and currently employs 119 full-time employees. The company went IPO on 2014-03-28. The firm is focused on developing, manufacturing and commercializing products for the global self-care market. The firm's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

VLG Intrinsic Value
127.04 GBX
Undervaluation 52%
Intrinsic Value
Price

See Also

What is Venture Life Group PLC's Other Long-Term Assets?
Other Long-Term Assets
59.6m GBP

Based on the financial report for Jun 30, 2025, Venture Life Group PLC's Other Long-Term Assets amounts to 59.6m GBP.

What is Venture Life Group PLC's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
188%

Over the last year, the Other Long-Term Assets growth was 2 249%. The average annual Other Long-Term Assets growth rates for Venture Life Group PLC have been 188% over the past three years .

Back to Top